251 related articles for article (PubMed ID: 36172365)
41. Serious consequences of Epstein-Barr virus infection: Hemophagocytic lymphohistocytosis.
Xu L; Guo X; Guan H
Int J Lab Hematol; 2022 Feb; 44(1):74-81. PubMed ID: 34709704
[TBL] [Abstract][Full Text] [Related]
42. Clinical Significance of Plasma Soluble MICB in Children With EBV-associated Hemophagocytic Lymphohistiocytosis.
Wei A; Zhang L; Ma H; Cui L; Zhang Q; Wang D; Chen S; Du J; Zhao X; Wang T; Zhang R; Zheng H; Li Z
J Pediatr Hematol Oncol; 2023 May; 45(4):e446-e454. PubMed ID: 36898046
[TBL] [Abstract][Full Text] [Related]
43. Treatment outcomes and prognostic factors for non- malignancy associated secondary hemophagocytic lymphohistiocytosis in children.
Pan H; Wang G; Guan E; Song L; Song A; Liu X; Yi Z; Sun LR
BMC Pediatr; 2020 Jun; 20(1):288. PubMed ID: 32517812
[TBL] [Abstract][Full Text] [Related]
44. An Easily Overlooked Disease: Hemophagocytic Syndrome.
Chen Y; Zhu YM; Gan YL; Jiang J; Jiang T
Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948476
[TBL] [Abstract][Full Text] [Related]
45. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol].
Xiao L; Xian Y; Dai BT; Su YC; Xiao JW; Zheng QC; Zhao XD; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824
[TBL] [Abstract][Full Text] [Related]
46. HLA-mismatched GPBSC infusion therapy in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: an observational study from a single center.
Song Y; Wang J; Wang Y; Wang Z
Stem Cell Res Ther; 2020 Jul; 11(1):265. PubMed ID: 32611452
[TBL] [Abstract][Full Text] [Related]
47. [Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Chinese children: a primary study on clinical characteristics and gene mutations].
Liu R; Shi X; Li J; Hu T; Cao J; Sun Y; Tong C; Liu H
Zhonghua Yi Xue Za Zhi; 2014 Jul; 94(25):1941-6. PubMed ID: 25253006
[TBL] [Abstract][Full Text] [Related]
48. Cytokine profiles as novel diagnostic markers of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
Han XC; Ye Q; Zhang WY; Tang YM; Xu XJ; Zhang T
J Crit Care; 2017 Jun; 39():72-77. PubMed ID: 28222313
[TBL] [Abstract][Full Text] [Related]
49. The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.
Smith MC; Cohen DN; Greig B; Yenamandra A; Vnencak-Jones C; Thompson MA; Kim AS
Int J Clin Exp Pathol; 2014; 7(9):5738-49. PubMed ID: 25337215
[TBL] [Abstract][Full Text] [Related]
50. Clinical laboratory Analysis of EB Virus Associated Hemophagocytic Lymphohistiocytosis in Children.
Hao G; Jiang L; Wen L; Guo W; Geng W; Li Q
Altern Ther Health Med; 2024 Apr; ():. PubMed ID: 38639627
[TBL] [Abstract][Full Text] [Related]
51. Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol.
Yanagaisawa R; Matsuda K; Ohga S; Kanegane H; Morimoto A; Okamoto Y; Ohara A; Fukushima K; Sotomatsu M; Nomura K; Saito AM; Horibe K; Ishii E; Nakazawa Y
Int J Hematol; 2019 May; 109(5):612-617. PubMed ID: 30788725
[TBL] [Abstract][Full Text] [Related]
52. Difficult Balance Between EBV Treatment and Posttransplant Immunosuppression: A Successful Transplant in a Child With Recurrent Epstein-Barr Virus-Induced Hemophagocytic Lymphohistiocytosis.
Fałkowska A; Prądzyńska K; Drabko K
Transplant Proc; 2021; 53(6):2035-2039. PubMed ID: 33933286
[TBL] [Abstract][Full Text] [Related]
53. Disparity Analysis of Clinical Features and Prognostic Evaluation of Hemophagocytic Lymphohistiocytosis in Pediatric and Adult Patients: A Retrospective Multicenter Study of 525 Cases in HHLWG.
Wang X; Zhou Y; Sun Q; Zhou H; Zhang Q; Shen Z; Huang J; Xue Y; Yan D; Fang Y; Sang W
Acta Haematol; 2023; 146(3):185-195. PubMed ID: 36623498
[TBL] [Abstract][Full Text] [Related]
54. Prognostic Value of Blood-Based Inflammatory Biomarkers in Secondary Hemophagocytic Lymphohistiocytosis.
Huang J; Yin G; Duan L; Tian T; Xu J; Wang J; Gao X; Cheng W; Liu L; Qiu H
J Clin Immunol; 2020 Jul; 40(5):718-728. PubMed ID: 32495220
[TBL] [Abstract][Full Text] [Related]
55. A Pediatric Case Report of Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis With Pericardial Effusion and Multiple Coronary Artery Aneurysms.
Sun G; Yao F; Yang Z
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e219-e222. PubMed ID: 31688637
[TBL] [Abstract][Full Text] [Related]
56. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis.
Toga A; Wada T; Sakakibara Y; Mase S; Araki R; Tone Y; Toma T; Kurokawa T; Yanagisawa R; Tamura K; Nishida N; Taneichi H; Kanegane H; Yachie A
J Infect Dis; 2010 Jun; 201(12):1923-32. PubMed ID: 20443735
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of coinfection in children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Qiang Q; Zhengde X; Shuang Y; Kunling S
J Pediatr Hematol Oncol; 2012 Mar; 34(2):e45-8. PubMed ID: 22146525
[TBL] [Abstract][Full Text] [Related]
58. Haemophagocytic lymphohistiocytosis secondary to Epstein-Barr and cytomegalovirus coinfection.
Nasir AZ; Khan N
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38806401
[TBL] [Abstract][Full Text] [Related]
59. [A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in an elderly woman].
Matsumoto S; Nishihara K; Hasegawa M; Satake S; Endo H; Arai H
Nihon Ronen Igakkai Zasshi; 2019; 56(4):525-531. PubMed ID: 31761859
[TBL] [Abstract][Full Text] [Related]
60. Pediatric hemophagocytic lymphohistiocytosis: A rarely diagnosed entity in a developing country.
Cleves D; Lotero V; Medina D; Perez PM; Patiño JA; Torres-Canchala L; Olaya M
BMC Pediatr; 2021 Sep; 21(1):411. PubMed ID: 34537050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
